Beijing CytoNiche Biotechnology Co., Ltd. was established by the research team of Professor Du Yanan from Tsinghua University School of Medicine, and was jointly established by Tsinghua University through equity participation.The core technologies were derived from the transformation of scientific and technological achievements of Tsinghua University.Its proprietary 3D FloTrix^® series of products and supporting processes provide an overall solution for the large-scale production and preparation of cell therapy products, and they are also proprietary innovative injection-type pharmaceutical excipient products that can be loaded with stem cells.